Report Detail

Request for Sample of this report

Pharma & Healthcare Global Ropivacaine Mesylate Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4537962
    • |
  • 30 June, 2023
    • |
  • Global
    • |
  • 102 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Ropivacaine Mesylate market size was valued at USD 895.2 million in 2022 and is forecast to a readjusted size of USD 1357.2 million by 2029 with a CAGR of 6.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Ropivacaine mesylate is a long-acting amide local anaesthetic agent for a spinal block and effectively blocks neuropathic pain. Ropivacaine blocks impulse conduction via reversible inhibition of sodium ion influx in nerve fibressup.
This report is a detailed and comprehensive analysis for global Ropivacaine Mesylate market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Ropivacaine Mesylate market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Ropivacaine Mesylate market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Ropivacaine Mesylate market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Ropivacaine Mesylate market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ropivacaine Mesylate
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ropivacaine Mesylate market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Akorn, Anant Pharmaceuticals, SGPharma and Nephron Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Ropivacaine Mesylate market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
2 mg/mL (0.2%)
5 mg/mL (0.5%)
7.5 mg/mL (0.75%)
10 mg/mL (1%)
Market segment by Application
Surgical Anesthesia
Major Nerve Block
Acute Pain Management
Other
Major players covered
Pfizer
Akorn
Anant Pharmaceuticals
SGPharma
Nephron Pharmaceuticals
Sintetica SA
AstraZeneca
Manus Aktteva Biopharma LLP
Zhejiang Xianju Pharmaceutical Co.,Ltd
Jiangsu Nhwa Pharmaceutical Co.,Ltd.
Yangzi River Pharmaceutical Group
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Nhwa Pharmaceutical Co.,Ltd
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ropivacaine Mesylate product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ropivacaine Mesylate, with price, sales, revenue and global market share of Ropivacaine Mesylate from 2018 to 2023.
Chapter 3, the Ropivacaine Mesylate competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ropivacaine Mesylate breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Ropivacaine Mesylate market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ropivacaine Mesylate.
Chapter 14 and 15, to describe Ropivacaine Mesylate sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Ropivacaine Mesylate
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Ropivacaine Mesylate Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 2 mg/mL (0.2%)
    • 1.3.3 5 mg/mL (0.5%)
    • 1.3.4 7.5 mg/mL (0.75%)
    • 1.3.5 10 mg/mL (1%)
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Ropivacaine Mesylate Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Surgical Anesthesia
    • 1.4.3 Major Nerve Block
    • 1.4.4 Acute Pain Management
    • 1.4.5 Other
  • 1.5 Global Ropivacaine Mesylate Market Size & Forecast
    • 1.5.1 Global Ropivacaine Mesylate Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Ropivacaine Mesylate Sales Quantity (2018-2029)
    • 1.5.3 Global Ropivacaine Mesylate Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Ropivacaine Mesylate Product and Services
    • 2.1.4 Pfizer Ropivacaine Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 Akorn
    • 2.2.1 Akorn Details
    • 2.2.2 Akorn Major Business
    • 2.2.3 Akorn Ropivacaine Mesylate Product and Services
    • 2.2.4 Akorn Ropivacaine Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Akorn Recent Developments/Updates
  • 2.3 Anant Pharmaceuticals
    • 2.3.1 Anant Pharmaceuticals Details
    • 2.3.2 Anant Pharmaceuticals Major Business
    • 2.3.3 Anant Pharmaceuticals Ropivacaine Mesylate Product and Services
    • 2.3.4 Anant Pharmaceuticals Ropivacaine Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Anant Pharmaceuticals Recent Developments/Updates
  • 2.4 SGPharma
    • 2.4.1 SGPharma Details
    • 2.4.2 SGPharma Major Business
    • 2.4.3 SGPharma Ropivacaine Mesylate Product and Services
    • 2.4.4 SGPharma Ropivacaine Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 SGPharma Recent Developments/Updates
  • 2.5 Nephron Pharmaceuticals
    • 2.5.1 Nephron Pharmaceuticals Details
    • 2.5.2 Nephron Pharmaceuticals Major Business
    • 2.5.3 Nephron Pharmaceuticals Ropivacaine Mesylate Product and Services
    • 2.5.4 Nephron Pharmaceuticals Ropivacaine Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Nephron Pharmaceuticals Recent Developments/Updates
  • 2.6 Sintetica SA
    • 2.6.1 Sintetica SA Details
    • 2.6.2 Sintetica SA Major Business
    • 2.6.3 Sintetica SA Ropivacaine Mesylate Product and Services
    • 2.6.4 Sintetica SA Ropivacaine Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Sintetica SA Recent Developments/Updates
  • 2.7 AstraZeneca
    • 2.7.1 AstraZeneca Details
    • 2.7.2 AstraZeneca Major Business
    • 2.7.3 AstraZeneca Ropivacaine Mesylate Product and Services
    • 2.7.4 AstraZeneca Ropivacaine Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 AstraZeneca Recent Developments/Updates
  • 2.8 Manus Aktteva Biopharma LLP
    • 2.8.1 Manus Aktteva Biopharma LLP Details
    • 2.8.2 Manus Aktteva Biopharma LLP Major Business
    • 2.8.3 Manus Aktteva Biopharma LLP Ropivacaine Mesylate Product and Services
    • 2.8.4 Manus Aktteva Biopharma LLP Ropivacaine Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Manus Aktteva Biopharma LLP Recent Developments/Updates
  • 2.9 Zhejiang Xianju Pharmaceutical Co.,Ltd
    • 2.9.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Details
    • 2.9.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Major Business
    • 2.9.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Product and Services
    • 2.9.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
  • 2.10 Jiangsu Nhwa Pharmaceutical Co.,Ltd.
    • 2.10.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Details
    • 2.10.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Major Business
    • 2.10.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Product and Services
    • 2.10.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Developments/Updates
  • 2.11 Yangzi River Pharmaceutical Group
    • 2.11.1 Yangzi River Pharmaceutical Group Details
    • 2.11.2 Yangzi River Pharmaceutical Group Major Business
    • 2.11.3 Yangzi River Pharmaceutical Group Ropivacaine Mesylate Product and Services
    • 2.11.4 Yangzi River Pharmaceutical Group Ropivacaine Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Yangzi River Pharmaceutical Group Recent Developments/Updates
  • 2.12 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
    • 2.12.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details
    • 2.12.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
    • 2.12.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Product and Services
    • 2.12.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
  • 2.13 Jiangsu Nhwa Pharmaceutical Co.,Ltd
    • 2.13.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd Details
    • 2.13.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd Major Business
    • 2.13.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Product and Services
    • 2.13.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Mesylate Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Developments/Updates

3 Competitive Environment: Ropivacaine Mesylate by Manufacturer

  • 3.1 Global Ropivacaine Mesylate Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Ropivacaine Mesylate Revenue by Manufacturer (2018-2023)
  • 3.3 Global Ropivacaine Mesylate Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Ropivacaine Mesylate by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Ropivacaine Mesylate Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Ropivacaine Mesylate Manufacturer Market Share in 2022
  • 3.5 Ropivacaine Mesylate Market: Overall Company Footprint Analysis
    • 3.5.1 Ropivacaine Mesylate Market: Region Footprint
    • 3.5.2 Ropivacaine Mesylate Market: Company Product Type Footprint
    • 3.5.3 Ropivacaine Mesylate Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ropivacaine Mesylate Market Size by Region
    • 4.1.1 Global Ropivacaine Mesylate Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Ropivacaine Mesylate Consumption Value by Region (2018-2029)
    • 4.1.3 Global Ropivacaine Mesylate Average Price by Region (2018-2029)
  • 4.2 North America Ropivacaine Mesylate Consumption Value (2018-2029)
  • 4.3 Europe Ropivacaine Mesylate Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Ropivacaine Mesylate Consumption Value (2018-2029)
  • 4.5 South America Ropivacaine Mesylate Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Ropivacaine Mesylate Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Ropivacaine Mesylate Sales Quantity by Type (2018-2029)
  • 5.2 Global Ropivacaine Mesylate Consumption Value by Type (2018-2029)
  • 5.3 Global Ropivacaine Mesylate Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Ropivacaine Mesylate Sales Quantity by Application (2018-2029)
  • 6.2 Global Ropivacaine Mesylate Consumption Value by Application (2018-2029)
  • 6.3 Global Ropivacaine Mesylate Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Ropivacaine Mesylate Sales Quantity by Type (2018-2029)
  • 7.2 North America Ropivacaine Mesylate Sales Quantity by Application (2018-2029)
  • 7.3 North America Ropivacaine Mesylate Market Size by Country
    • 7.3.1 North America Ropivacaine Mesylate Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Ropivacaine Mesylate Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Ropivacaine Mesylate Sales Quantity by Type (2018-2029)
  • 8.2 Europe Ropivacaine Mesylate Sales Quantity by Application (2018-2029)
  • 8.3 Europe Ropivacaine Mesylate Market Size by Country
    • 8.3.1 Europe Ropivacaine Mesylate Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Ropivacaine Mesylate Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ropivacaine Mesylate Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Ropivacaine Mesylate Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Ropivacaine Mesylate Market Size by Region
    • 9.3.1 Asia-Pacific Ropivacaine Mesylate Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Ropivacaine Mesylate Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Ropivacaine Mesylate Sales Quantity by Type (2018-2029)
  • 10.2 South America Ropivacaine Mesylate Sales Quantity by Application (2018-2029)
  • 10.3 South America Ropivacaine Mesylate Market Size by Country
    • 10.3.1 South America Ropivacaine Mesylate Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Ropivacaine Mesylate Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ropivacaine Mesylate Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Ropivacaine Mesylate Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Ropivacaine Mesylate Market Size by Country
    • 11.3.1 Middle East & Africa Ropivacaine Mesylate Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Ropivacaine Mesylate Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Ropivacaine Mesylate Market Drivers
  • 12.2 Ropivacaine Mesylate Market Restraints
  • 12.3 Ropivacaine Mesylate Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ropivacaine Mesylate and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ropivacaine Mesylate
  • 13.3 Ropivacaine Mesylate Production Process
  • 13.4 Ropivacaine Mesylate Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ropivacaine Mesylate Typical Distributors
  • 14.3 Ropivacaine Mesylate Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Ropivacaine Mesylate. Industry analysis & Market Report on Ropivacaine Mesylate is a syndicated market report, published as Global Ropivacaine Mesylate Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Ropivacaine Mesylate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,686.56
    		4,029.84
    		5,373.12
    		3,201.60
    		4,802.40
    		6,403.20
    		530,108.40
    		795,162.60
    		1,060,216.80
    		292,772.40
    		439,158.60
    		585,544.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo